Equally, tumor- or therapeutically-triggered hypoxia in the tumor microenvironment (TME) may increase FCGR2B expression on mononuclear cells and macrophages, thus hindering their ability to phagocytose tumor cells [29]. The gene discussed is FCGR2B; the disease is neoplasm.